pentobarbital will minimize the extent or outcome of guanfacine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Strong or moderate CYP3A4 inducers considerably decrease guanfacine plasma concentrations and elimination fifty percent-existence.Following halting a CYP3A4 inducer, as the effects in the induc